
BULLOUS PEMPHIGOID
Get a global overview and learn all about the changing world of Bullous Pemphigoid
Science in Bullous Pemphigoid
Get a 360º view and stay updated on Bullous Pemphigoid with content selected for you
Get a global overview and learn all about the changing world of Bullous Pemphigoid
Get a 360º view and stay updated on Bullous Pemphigoid with content selected for you
The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.
Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more
In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more
Many factors, including older age and multimorbidity, are associated with mortality in bullous pemphigoid. Read this article to find out more
The heterogeneous presentation of bullous pemphigoid may shed light on why patients are underdiagnosed. Read the article to learn more
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.